Evidence map›Paper›PMID 29514938›Full record

ArticleJournal of clinical microbiology2018

Comprehensive Molecular Approach for Characterization of Hepatitis E Virus Genotype 3 Variants.

Bo Wang, Dominik Harms, C Patrick Papp, Sandra Niendorf, Sonja Jacobsen, Marc Lütgehetmann, Sven Pischke, Heiner Wedermeyer, Jörg Hofmann, C-Thomas Bock

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Hepatitis E virus genotype 3 microbiological surveillance by the Spanish Reference Laboratory: geographic distribution and phylogenetic analysis of subtypes from 2009 to 2019.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Article
  16. Viruses · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Bo WangDivision of Viral Gastroenteritis, Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.ORCID 0000-0002-8560-9071
Dominik HarmsDivision of Viral Gastroenteritis, Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
C Patrick PappDivision of Viral Gastroenteritis, Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Sandra NiendorfDivision of Viral Gastroenteritis, Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Sonja JacobsenDivision of Viral Gastroenteritis, Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Marc LütgehetmannInstitute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Sven PischkeFirst Medical Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Heiner WedermeyerGerman Center for Infection Research (DZIF), Braunschweig, Germany.
Jörg HofmannInstitute of Medical Virology, Charité University Medicine, Berlin, Germany.
C-Thomas BockDivision of Viral Gastroenteritis, Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany BockC@rki.de.ORCID 0000-0002-2773-486X
Robert Koch Institute · DEUniversität Hamburg · DEMedizinische Hochschule Hannover · DEVivantes Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autochthonous hepatitis E virus genotype 3 (HEV-3) infections in industrialized countries are more frequent than previously assumed. HEV-3 is zoonotic and the causal pathogen of chronic hepatitis E. According to the latest classification of the family

Indexed as

Genetic VariationGenotypeCluster AnalysisFecesHepatitis EHepatitis E virusHumansPhylogenyReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionSequence Analysis, DNASequence HomologySerumViral Loadchronic hepatitis Ecomplete genome amplificationdetectionhepatitis E virusHEV-3 subtypesHEV-3 variantsPCRquantification

Identifiers

PMID29514938
PMCPMC5925713
OpenAlexW2791966766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.